Stay updated on Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Record History now shows a new revision entry: v3.3.2, replacing the earlier v3.3.1. This is a metadata update to the page's version history and does not affect study data or other page content.
    Difference
    0.1%
    Check dated 2025-12-01T12:53:08.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added revision v3.3.1 and removed revision v3.2.0 from the record history.
    Difference
    0.1%
    Check dated 2025-11-24T04:11:42.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed the lapse in government funding notice at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2025-11-16T16:57:13.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The new screenshot shows an updated submission date in the Study Record Versions section for NCT04736589, while the rest of the page content remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-02T07:20:57.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a government operating-status notice and updated version to v3.2.0; removed the previous v3.1.0 tag.
    Difference
    13%
    Check dated 2025-10-04T16:55:16.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Version tag updated from v3.0.2 to v3.1.0, indicating an updated release.
    Difference
    0.3%
    Check dated 2025-09-27T10:59:40.000Z thumbnail image

Stay in the know with updates to Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page.